MYC Expression in Concert with BCL2 and BCL6 Expression Predicts Outcome in Chinese Patients with Diffuse Large B-Cell Lymphoma, Not Otherwise Specified

Por Yan, Li-Xu, Liu, Yan-Hui, Luo, Dong-Lan, Zhang, Fen, Cheng, Yu, Luo, Xin-Lan, Xu, Jie, Cheng, Jie, Zhuang, Heng-Guo
Publicado em 2014

Correction: MYC Expression in Concert With BCL2 and BCL6 Expression Predicts Outcome in Chinese Patients With Diffuse Large B-Cell Lymphoma, Not Otherwise Specified

Por Yan, Li-Xu, Liu, Yan-Hui, Luo, Dong-Lan, Zhang, Fen, Cheng, Yu, Luo, Xin-Lan, Xu, Jie, Cheng, Jie, Zhuang, Heng-Guo
Publicado no PLoS One (2018)

Overexpression of SRC‐3 promotes esophageal squamous cell carcinoma aggressiveness by enhancing cell growth and invasiveness

Por Xu, Fang‐Ping, Liu, Yan‐Hui, Luo, Xin‐Lan, Zhang, Fen, Zhou, Hai‐Yu, Ge, Yan, Liu, Chao, Chen, Jie, Luo, Dong‐Lan, Yan, Li‐Xu, Mei, Ping, Xu, Jie, Zhuang, Heng‐Guo
Publicado no Cancer Med (2016)

Immunophenotypic features and t(14;18) (q32;q21) translocation of Chinese follicular lymphomas helps to distinguish subgroups

Por Zhang, Fen, Yan, Li-Xu, Lin, Su-Xia, Ye, Zi-Yin, Zhuang, Heng-Guo, Yun, Jing-Ping, Lin, Han-Liang, Luo, Dong-Lan, Xu, Fang-Ping, Luo, Xin-Lan, Cheng, Jie, Zhang, Ke-Ping, Liu, Yan-Hui
Publicado em 2013

PIK3R1 targeting by miR-21 suppresses tumor cell migration and invasion by reducing PI3K/AKT signaling and reversing EMT, and predicts clinical outcome of breast cancer

Por YAN, LI-XU, LIU, YAN-HUI, XIANG, JIAN-WEN, WU, QI-NIAN, XU, LEI-BO, LUO, XIN-LAN, ZHU, XIAO-LAN, LIU, CHAO, XU, FANG-PING, LUO, DONG-LAN, MEI, PING, XU, JIE, ZHANG, KE-PING, CHEN, JIE
Publicado no Int J Oncol (2015)